LAPORAN KASUS: ANALISIS KOMBINASI PENGGUNAAN HEPATOPROTEKTOR PADA CEDERA HATI KARENA INFEKSI BAKTERI STREPTOCOCCUS VIRIDANS
DOI:
https://doi.org/10.36387/jiis.v9i2.2179Keywords:
Ursodeoxycholic acid, Curcuma, AST, ALT, BilirubinAbstract
Streptococcus viridans is one of the bacteria that can cause Community-Acquired Pneumonia (CAP). CAP disease has a higher prevalence of non-alcohol-related fatty liver disease (NAFLD). Continuous increase in fat levels in the liver triggered by pneumonia can cause inflammation in the liver, it causes a rapid decline in liver function and results in increased levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and total bilirubin. The use of hepatoprotectors in conditions of impaired liver function is essential to improve liver cell regeneration and promote liver detoxification. One of the drugs and supplements that can act as a hepatoprotector is ursodeoxycholic acid (UDCA) and Curcuma. Here we report the use of hepatoprotector drugs in cases of Community-Acquired Pneumonia (CAP) disease due to Streptococcus viridans bacteria in patients without comorbidities with the results of liver function test examinations from the beginning of hospital admission, during treatment, until the patient is discharged. The purpose of our case report is to illustrate the effect of the combined use of UDCA and Curcuma drugs on liver injury due to Streptococcus viridans bacterial infection in order to prevent complications, morbidity, mortality and improve the quality of life of patients. Based on the case reports that we present, the combined use of UDCA and Curcuma drugs as hepatoprotectors can improve liver function with reduced parameters of AST, ALT, and total bilirubin levels.
References
Ahmed, M. F., Abbasi, Z., Das, S., Aggarwal, A., & Sahni, S. (2020). Complicated Isolated Liver Abscess Caused by Viridans Group Streptococci Leading to Right Hepatectomy. Cureus, 12(7), e9149. https://doi.org/10.7759/cureus.9149
Almirall, J., Serra-Prat, M., Bolíbar, I., & Balasso, V. (2017). Risk Factors for Community-Acquired Pneumonia in Adults: A Systematic Review of Observational Studies. Respiration, 94(3), 299–311. https://doi.org/10.1159/000479089
Bajpai, V., Gupta, E., Mitra, L. G., Kumar, H., Maiwall, R., Soni, K. D., & Gupta, A. (2019). Spectrum of respiratory viral infections in liver disease patients with cirrhosis admitted in critical care unit. Journal of Laboratory Physicians, 11(4), 356–360. https://doi.org/10.4103/JLP.JLP_6_19
Chappell, L. C., Bell, J. L., Smith, A., Linsell, L., Juszczak, E., Dixon, P. H., Chambers, J., Hunter, R., Dorling, J., Williamson, C., Thornton, J. G., & PITCHES study group. (2019). Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet, 394(10201), 849–860. https://doi.org/10.1016/S0140-6736(19)31270-X
Choi, S. H., Cesar, A., Snow, T. A. C., Saleem, N., Arulkumaran, N., & Singer, M. (2023). Respiratory fluoroquinolone monotherapy vs. β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials. International Journal of Antimicrobial Agents, 62(3), 106905. https://doi.org/10.1016/j.ijantimicag.2023.106905
Dkhil, M. A., Abdel Moneim, A. E., Hafez, T. A., Mubaraki, M. A., Mohamed, W. F., Thagfan, F. A., & Al-Quraishy, S. (2019). Myristica fragrans Kernels Prevent Paracetamol-Induced Hepatotoxicity by Inducing Anti-Apoptotic Genes and Nrf2/HO-1 Pathway. International Journal of Molecular Sciences, 20(4), 993. https://doi.org/10.3390/ijms20040993
Farashbandi, A. L., Shariati, M., & Mokhtari, M. (2021). Comparing the Protective Effects of Curcumin and Ursodeoxycholic Acid after Ethanol-Induced Hepatotoxicity in Rat Liver. Ethiopian Journal of Health Sciences, 31(3), 673–682. https://doi.org/10.4314/ejhs.v31i3.25
Farzaei, M. H., Zobeiri, M., Parvizi, F., El-Senduny, F. F., Marmouzi, I., Coy-Barrera, E., Naseri, R., Nabavi, S. M., Rahimi, R., & Abdollahi, M. (2018). Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective. Nutrients, 10(7), 855. https://doi.org/10.3390/nu10070855
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003). Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology, 125(2), 437–443. https://doi.org/10.1016/s0016-5085(03)00907-7
Freitas, M., Castelo, A., Petty, G., Gomes, C. E., & Carvalho, E. (2006). Viridans streptococci causing community acquired pneumonia. Archives of Disease in Childhood, 91(9), 779–780. https://doi.org/10.1136/adc.2006.094847
Gheibi, S., Gouvarchin Ghaleh, H. E., Motlagh, B. M., Azarbayjani, A. F., & Zarei, L. (2019). Therapeutic effects of curcumin and ursodexycholic acid on non-alcoholic fatty liver disease. Biomedicine & Pharmacotherapy, 115, 108938. https://doi.org/10.1016/j.biopha.2019.108938
Giannini, E. G., Testa, R., & Savarino, V. (2005). Liver enzyme alteration: a guide for clinicians. CMAJ : Canadian Medical Association Journal, 172(3), 367–379. https://doi.org/10.1503/cmaj.1040752
Gjurašin, B., Jeličić, M., Kutleša, M., & Papić, N. (2022). The Impact of Nonalcoholic Fatty Liver Disease on Severe Community-Acquired Pneumonia Outcomes. Life, 13(1), 36. https://doi.org/10.3390/life13010036
Herrero, R., Sánchez, G., Asensio, I., López, E., Ferruelo, A., Vaquero, J., Moreno, L., de Lorenzo, A., Bañares, R., & Lorente, J. A. (2020). Liver-lung interactions in acute respiratory distress syndrome. Intensive Care Medicine Experimental, 8(Suppl 1), 48. https://doi.org/10.1186/s40635-020-00337-9
Huang, L., Li, S., Chen, J., Zhu, Y., Lan, K., Zeng, L., Jiang, X., & Zhang, L. (2023). Efficacy and safety of ursodeoxycholic acid in children with cholestasis: A systematic review and meta-analysis. PloS One, 18(1), e0280691. https://doi.org/10.1371/journal.pone.0280691
Huang, Y., Liu, A., Liang, L., Jiang, J., Luo, H., Deng, W., Lin, G., Wu, M., Li, T., & Jiang, Y. (2018). Diagnostic value of blood parameters for community-acquired pneumonia. International Immunopharmacology, 64(1), 10–15. https://doi.org/10.1016/j.intimp.2018.08.022
Idrissova, L., Malhi, H., Werneburg, N. W., LeBrasseur, N. K., Bronk, S. F., Fingas, C., Tchkonia, T., Pirtskhalava, T., White, T. A., Stout, M. B., Hirsova, P., Krishnan, A., Liedtke, C., Trautwein, C., Finnberg, N., El-Deiry, W. S., Kirkland, J. L., & Gores, G. J. (2015). TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess. Journal of Hepatology, 62(5), 1156–1163. https://doi.org/10.1016/j.jhep.2014.11.033
Joseph, A., & Samant, H. (2024). Jaundice. In StatPearls. Treasure Island. http://www.ncbi.nlm.nih.gov/pubmed/23735764
Kanda, T., Matsuoka, S., Yamazaki, M., Shibata, T., Nirei, K., Takahashi, H., Kaneko, T., Fujisawa, M., Higuchi, T., Nakamura, H., Matsumoto, N., Yamagami, H., Ogawa, M., Imazu, H., Kuroda, K., & Moriyama, M. (2018). Apoptosis and non-alcoholic fatty liver diseases. World Journal of Gastroenterology, 24(25), 2661–2672. https://doi.org/10.3748/wjg.v24.i25.2661
Kaufmann, B., Reca, A., Wang, B., Friess, H., Feldstein, A. E., & Hartmann, D. (2021). Mechanisms of nonalcoholic fatty liver disease and implications for surgery. Langenbeck’s Archives of Surgery, 406(1), 1–17. https://doi.org/10.1007/s00423-020-01965-1
Liaw, F. Y., Wang, C. C., Chang, Y. W., & Chen, S. J. (2012). Community-acquired Streptococcus viridans pneumonia in a healthy child. Indian Pediatrics, 49(4), 324–326. http://www.ncbi.nlm.nih.gov/pubmed/22565080
Liu, S., Tong, X., Ma, Y., Wang, D., Huang, J., Zhang, L., Wu, M., Wang, L., Liu, T., & Fan, H. (2019). Respiratory Fluoroquinolones Monotherapy vs. β-Lactams With or Without Macrolides for Hospitalized Community-Acquired Pneumonia Patients: A Meta-Analysis. Frontiers in Pharmacology, 10, 106905. https://doi.org/10.3389/fphar.2019.00489
Luedde, T., Kaplowitz, N., & Schwabe, R. F. (2014). Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology, 147(4), 765-783.e4. https://doi.org/10.1053/j.gastro.2014.07.018
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., Griffin, M. R., Metersky, M. L., Musher, D. M., Restrepo, M. I., & Whitney, C. G. (2019). Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine, 200(7), e45–e67. https://doi.org/10.1164/rccm.201908-1581ST
Paradies, G., Paradies, V., Ruggiero, F. M., & Petrosillo, G. (2014). Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World Journal of Gastroenterology, 20(39), 14205–14218. https://doi.org/10.3748/wjg.v20.i39.14205
Pérez-Carreras, M., Del Hoyo, P., Martín, M. A., Rubio, J. C., Martín, A., Castellano, G., Colina, F., Arenas, J., & Solis-Herruzo, J. A. (2003). Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology, 38(4), 999–1007. https://doi.org/10.1053/jhep.2003.50398
Podder, V., Patel, P., & Sadiq, N. M. (2024). Levofloxacin. In StatPearls. Treasure Island. http://www.ncbi.nlm.nih.gov/pubmed/22114510
Simental-Mendía, M., Sánchez-García, A., & Simental-Mendía, L. E. (2020). Effect of ursodeoxycholic acid on liver markers: A systematic review and meta-analysis of randomized placebo-controlled clinical trials. British Journal of Clinical Pharmacology, 86(8), 1476–1488. https://doi.org/10.1111/bcp.14311
Ughasoro, M. D., Adimorah, G. N., Chukwudi, N. K., Nnakenyi, I. D., Iloh, K. K., & Udemba, C. E. (2019). Reductive effect of ursodeoxycholic acid on bilirubin levels in neonates on phototherapy. Clinical and Experimental Gastroenterology, 12, 349–354. https://doi.org/10.2147/CEG.S207523
Yang, K., Chen, J., Zhang, T., Yuan, X., Ge, A., Wang, S., Xu, H., Zeng, L., & Ge, J. (2022). Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis. Frontiers in Immunology, 13, 949746. https://doi.org/10.3389/fimmu.2022.949746
Yang, X., Xu, L., Zhao, H., Xie, T., Wang, J., Wang, L., & Yang, J. (2023). Curcumin protects against cerebral ischemia-reperfusion injury in rats by attenuating oxidative stress and inflammation: A meta-analysis and mechanism exploration. Nutrition Research, 113, 14–28. https://doi.org/10.1016/j.nutres.2023.02.009
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Jurnal Ilmiah Ibnu Sina
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
